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. The features distinguishing humans from apes have long been attributed to differences in gene expression 2 , and aberrant gene expression lies at the heart of multiple diseases. Thus, identifying the DNA sequences that are required for regulating gene expression -called cis-regulatory modules (CRMs) -can both expand our understanding of biology and have applications in several fields, including evolution and medicine. For example, most of the genetic variants that are significantly associated with susceptibility to disease do not lie in protein-coding regions 3 , and we surmise that many affect the regulation of gene expression.
Three major approaches have emerged for predicting CRMs. The first is to search genomic DNA for clusters of short motifs that are needed for the specific binding of transcription factors. Although CRMs should contain multiple such motifs, this approach towards identifying CRMs has had limited success. A second approach for identifying CRMs involves comparing homologous, non-coding DNA sequences between related species. These methods can reveal important subsets of conserved CRMs that are under purifying selection, such as developmental enhancers, but they miss lineage-specific ones. More recently, high-throughput, direct assays for DNA sequences with epigenetic features that are characteristic of regulatory regions provide a third approach that has a potentially high predictive power for identifying CRMs. This method, which involves mapping the locations of transcription factor binding and histone modifications in a wide range of tissues and developmental stages, yields an unbiased genomic view of potential gene regulatory regions that is not restricted to conserved regions or those regions with known regulatory motifs.
We briefly review the major types of CRMs being studied in animals and then review the strengths and weaknesses of the three approaches to CRM prediction, assessing the success rates of each. We suggest ways to use the three approaches in combination to improve predictions and discuss important questions for future research. Improvements in CRM prediction and classification are already leading to advances in understanding how genetic variants affect susceptibility to disease [4] [5] [6] [7] . Our emphasis in this Review is to assess the efficacy of these methods and to suggest ways in which they can be improved. Readers are referred to other recent reviews for more details on the biochemical features of chromatin around CRMs [8] [9] [10] [11] [12] [13] , prediction methods that are based on conservation and motifs 14, 15 and earlier comparisons of the different approaches 16, 17 .
Classes of cis-regulatory modules
Regulation of gene expression involves an interaction between transcription factors and CRMs, and it is important to be clear about how to refer to the DNA sequences that transcription factors can bind (BOX 1) . In this Review, we emphasize the transcription factor binding sites (TFBSs) that are occupied in living cells. The emphasis on in vivo occupancy is crucial. Biochemical assays in solution, such as electrophoretic mobility shift Nature Reviews | Genetics 
Epigenetic features
Molecules and chemical modifications that are associated with genomic DNA, including covalent modifications of DNA and histones, RNA transcribed from the DNA, occupancy of DNA by transcription factors and accessibility of DNA in chromatin to DNases.
Transcription factor binding site (TFBS) . A short segment of DNA that is bound by a particular transcription factor in vivo.
TFBS motif
A short string of DNA base pairs (often 6-10 bp long) constituting the sequence recognized by the DNA-binding domain of the transcription factor.
assays, in vitro footprints and capture of transcriptionfactor-bound sequences, can define the sequence that is required for recognition of DNA by transcription factors; algorithms that assess DNA sequence similarity to a TFBS motif will therefore be able to detect millions of motif instances in a mammalian genome 18, 19 . Although any motif instance could potentially be bound in vivo, only about 1 in 500 actually are bound in organisms with large genomes 18 . As a specific example, the mouse genome contains ~8 million instances of a match to the GATA-binding factor 1 (GATA1) binding site motif, but only ~15,000 DNA segments (some with multiple motif instances) are bound by this transcription factor in erythroid cells 18, 20 . CRMs in animal genomes are usually placed into one of three categories, which are defined by their role in gene expression. The ability of the three prediction methods to detect a CRM depends on the properties of each particular CRM class. This Review covers work in both flies (specifically, Drosophila melanogaster) and mammals because a large number of studies have been done in these species, and the fundamental mechanisms of regulation are similar in insects and mammals. However, some genomic features and proteins are present only in one clade, and the smaller size of the fly genome coupled with the lower proportion of noncoding DNA may contribute to a greater success of CRM predictions in this species.
Promoters.
A promoter directs RNA polymerase to initiate at the transcription start site (TSS) 21 . In promoters for RNA polymerase II, general transcription factors bind to a core promoter of ~100 bp around the TSS and facilitate binding of the polymerase complex 8 
Some core promoters contain well-known motifs, such as a TATA box, and have a discrete start site for transcription; however, most promoters in mammalian genomes are GC-and CpG-rich regions that lack TATA boxes and tend to support initiation of transcription at a broad range of positions within a roughly 100 bp interval 22 . The heterogeneity in sequence composition and genomic structure of promoters has complicated the accurate prediction of this CRM class on the basis of single sequences. Furthermore, CpG islands are not 96, 129 . Most cis-regulatory modules (CRMs) are comprised of a cluster of TFBSs. A TFBS motif is a short sequence (often 6-10 bp; coloured circles in panel a of the figure) found within a TFBS that is required for transcription factor binding, as demonstrated by loss of binding following mutation of the sequence. The motif can be characterized as a TFBS consensus or as a position-specific weight matrix. Any match to a TFBS motif in a DNA sequence is a motif instance.
The size of a TFBS is determined by the resolution of the experimental technique used. Using ChIP followed by high-throughput sequencing (ChIP-seq) 130, 131 , binding of transcription factors in vivo can be mapped to a DNA segment ~200-300 bp in length (panel a of the figure; note that the TFBS mapped for the bound red motif includes DNA also bound by the orange protein). DNase footprints 100, 116 and the recently developed ChIP-exo 117 provide higher resolution, approaching that of the bound motif instance.
Different classes of CRM (such as promoters, enhancers, silencers or insulators) share some chromatin modifications (as shown by circles of different colours on the histone tails extending from nucleosomes in panel b of the figure), such as acetylation (Ac) of histones H3 and H4 for all three classes 132 (for simplicity, the Ac is only shown on H4 in the figure, H4Ac) and monomethylation of histone H3 at lysine 4 (H3K4me1) for both enhancers and insulators (and distal to the transcriptional start site (TSS) around promoters) 108 . Other modifications are distinctive for a CRM class. Active promoters have a nucleosome-depleted region just upstream from the TSS, flanked by nucleosomes with high levels of H3K4me3 (REFS 81, 132) . Promoters can also be identified by ChIP-seq for RNA polymerase II (RNA Pol II). Nucleosomes at enhancers have high levels of H3K4me1 (REF. 108) and are positioned adjacent to the TFBSs 133 . The co-activator p300 is frequently found at enhancers 108 . Insulators that work by blocking enhancement require binding by CTCF in mammals 39 .
Promoter
The DNA sequence that directs RNA polymerase to initiate transcription at the correct place.
TFBS consensus
A string of DNA nucleotides describing the most frequently occurring short sequences in a collection of TFBSs, usually including ambiguous positions (for example, R refers to G or A nucleotides).
Position-specific weight matrix (PWM) . A matrix providing the frequency at which each nucleotide is found at the positions of the TFBS consensus.
Silencers
DNA sequences that cause reduced expression of their target gene (or genes).
Insulators
DNA sequences that control the ability of an enhancer to regulate a promoter by an enhancer blocking activity or a domain barrier function or both.
Position effects
The observation that the level of expression of some genes is affected by their position on chromosomes, with normal level of expression in one location but altered expression when translocated. For example, proximity to centromeres is associated with lowered expression for many genes.
False positive
In a prediction experiment, a case in which the prediction is positive, but the true class is negative.
Sensitivity
In a prediction experiment, the proportion of the true class that is predicted by the method: that is, (number of true positives) / (number of true positives + number of false negatives).
Positive predictive value
In a prediction experiment, the proportion of positive predictions that are true positives. present in D. melanogaster. However, promoters reside in chromatin with distinctive modifications
, and they can be identified by mapping the start sites for transcription (see below). The functional and mechanistic implications of the differences in promoter classes along with distinct chromatin modifications was recently reviewed 13 .
Enhancers and silencers.
Enhancers [23] [24] [25] and silencers
26
are defined operationally by their positive or negative effects, respectively, on a reporter gene after transfer into a transgenic animal or transfected cells in culture. They can act independently of position and orientation in gene transfer assays. However, depending on the transenvironment in a cell, a given DNA segment can switch between enhancing and silencing, presumably reflecting the recruitment of co-activators and co-repressors, respectively 27, 28 . Hence the successful prediction of enhancers will probably identify some silencers as well. Currently, few silencers are well-characterized, and they are not covered further in this Review.
Enhancers can be located close to their target promoter 29 , but many of them are located a long distance away; an enhancer for the mouse sonic hedgehog (Shh) gene is 1 Mb away from the Shh promoter 30 . An enhancer contains multiple TFBSs
, and this multiplicity is a requirement for enhancement 31, 32 . Genes can have multiple distinct enhancers that drive expression in specific tissues depending on the particular TFBS motifs and the transcription factors that bind to them 1, [33] [34] [35] . The variability in the distance of enhancers from a TSS and the diversity in their composition make the prediction of enhancers particularly challenging. The set of mammalian transcription factors, which is estimated to contain at least 1,000 in number, bind to hundreds of TFBS motifs, but these motifs are short and the vast majority of motif instances are not bound by a transcription factor. As will be developed in a later section, these sequence features are not sufficient for consistently accurate predictions of enhancers. However, including signatures of purifying selection and especially direct evidence for distinctive epigenetic features (BOX 1) improves the prediction accuracy.
Insulators.
Insulators are CRMs that restrict the effect of long-range regulatory modules, such as enhancers, so that they act on the appropriate promoter target 36, 37 . One way to do this is by an enhancer-blocking activity. When located between an enhancer and a target promoter, such an insulator can block the activity of the enhancer and thereby reduce gene expression 38 . CTCF is a protein that is required for the enhancer-blocking activity of mammalian insulators 39 
, whereas Drosophila species have at least four additional proteins that are sufficient for enhancer-blocking activity, some of which can be identified in other insects 40 . Insulators that serve as barriers can prevent position effects when they surround a stably integrated reporter gene 41 , presumably by blocking the spread of repressive heterochromatin from the site of integration into the reporter gene. This is a separate activity from enhancer blocking, and it requires different proteins, such as upstream stimulatory factor (USF), which in turn recruits histone-modifying enzymes 42 . The enhancer blocking and barrier activities can occur together in some insulators or separately in others.
As for enhancers, an insulator can be located almost anywhere relative to a gene, and thus location offers no predictive power. Known insulators are located in chromatin with a histone modification profile that is similar to that of enhancers, but the requirement for CTCF distinguishes enhancer-blocking insulators from enhancers
. A major complication is that CTCF has many functions in addition to insulation 43 . Thus, finding CTCF-bound DNA segments should identify most instances of this type of insulator 44 , but many of the CTCF-bound segments will not necessarily be insulators. The challenge is to identify those other functions.
Single-genome bioinformatic approaches
The observation that clusters of TFBS motifs are necessary for transcription factor binding to CRMs motivated initial motif-based approaches for predicting enhancers and promoters. The advantage of these approaches is that predictions can be made using only genomic DNA sequence and models of the TFBS motifs for the transcription factors involved in the process under study
. However, clusters of TFBS motifs are widespread in large genomes, and alone they are not sufficient to predict transcription factor binding (for example, epigenetic marks are required). Thus, genome-wide CRM predictions based on transcription factor motifs typically make many false-positive predictions and consequently have low validation rates. When the search space can be reduced -for example, by interrogating species with smaller genomes, restricting to relevant genes or using general epigenetic marks -TFBS motif approaches can be effective. Unlike more general epigenetic marks, they can also be useful for classifying elements based on the particular transcription factors involved. However, for many biological processes, the transcription factors involved are not fully known, and so these approaches cannot be applied.
Applications in which transcription factors and TFBSs are known. In early applications, detailed information about transcription factors that are involved in muscle determination, such as myogenic factors (MYFs) and myocyte-enhancing factor 2 (MEF2), and their TFBS motifs enabled the prediction of elements that are active in muscle based on clustering of the TFBS motifs 45, 46 ( FIG. 1a; TABLE 1 ). These and related methods can find up to two-thirds of known muscle enhancers, but the validation rate can be low 45 . In D. melanogaster, knowledge of the transcription factors and their cognate TFBS motifs that regulate expression of genes controlling early development enabled several approaches to finding clusters of TFBS motifs that were relevant to different developmental process [47] [48] [49] [50] [51] . All had good sensitivity, in that each found at least one novel enhancer that was active in transgenic flies, but in most cases the predictions had a low positive predictive value (14-33%). Modelling Position-specific scoring matrix (PSSM) . A matrix providing the log ratio of frequency at which each nucleotide is found at the positions of the TFBS consensus relative to a background model.
TFBS motif instances
A match to a TFBS consensus or motif matrix within a longer DNA sequence (for example, a genome or chromosome).
Specificity
In a prediction experiment, the proportion of the false class that is not predicted by the method: that is, (number of true negatives) / (number of true negatives + number of false positives).
Logistic regression
A form of regression used when the output is binary. The predictor is a linear combination of the input variables transformed with the logistic function to form a probability. For classification, the coefficients are learned to maximize the (log) conditional likelihood of the training data.
matches to TFBS motif matrices as a thermodynamic affinity instead of making binary calls on TFBS motif instances has a substantially higher success rate, probably because many weak matches were able to contribute to the predictions 51 . In this case, only known segmentation genes were investigated; in general, the larger the search domain for predicting CRMs (for example, the whole genome), the lower the positive predictive value.
Applications in which transcription factors and TFBSs are unknown. When relevant transcription factors and motifs are unknown, motif discovery and CRM discovery can be performed simultaneously. For example, the CisModule software 52 (TABLE 1) models TFBS motifs and CRMs simultaneously. When applied to the muscle expression data set described above, this approach recovered some of the known TFBS motifs and showed good specificity in discriminating the true muscle CRMs from random sequences 52 . Training models to discriminate different classes of CRMs (rather than just CRMs from the background) can improve the inference of TFBS motifs and CRMs. Smith et al. 53 combined known motifs with motifs that were discovered to be discriminative between data sets in promoter proximal regions to construct a logistic regression model that can significantly predict tissue-specific expression in 45 of the 56 human and mouse tissues that were considered. The ability to discover novel TFBS motifs, especially in the process of CRM identification and classification, will remain important as long as TFBS motifs have not been comprehensively defined.
Future prospects. As collections of transcription factors and their cognate TFBS motifs are more completely defined, a promising future direction is to build quantitative models that predict expression levels under diverse conditions for both naturally occurring and synthetic CRMs. Impressive success has been achieved for synthetic promoters in yeast using thermodynamic models of binding affinity of transcription factors to DNA and to each other 54 . As we strive for an understanding of the regulatory code, experiments such as these will reveal how complete (or lacking) our knowledge is.
Comparative genomics approaches
Assumptions and approaches. Comparative genomics approaches for CRM prediction assume that the DNA sequences involved in gene regulation have remained significantly more similar than non-functional DNA across a wide phylogenetic span, such as multiple species of Drosophila or many eutherian mammals. Sequence changes in these regions are thus more likely to show signatures of purifying selection (FIG. 1b) . Although this assumption holds for most transcription factor coding sequences, it is not uniformly true for CRMs 55, 56 , as shown in FIG. 2 . Thus, comparative genomics approaches can be effective only for identifying the subset of CRMs that were under strong purifying selection since the separation of the species under comparison, and they will not reveal lineage-specific, recently evolved CRMs.
Using only signals for evolutionary constraint. Evidence of strong evolutionary constraint in non-coding DNA, without other information such as TFBS motifs, has been used successfully as a de novo predictor of CRMs (TABLE 1) . This approach has been applied both at the level of a single TFBS and of an entire CRM.
In alignments of orthologous sequences from a diverse set of mammals, the non-coding regions contain blocks with little or no change among species surrounded by blocks with sequence differences (FIG. 1b) . These conserved blocks are interpreted as functional DNA sequences in which substitutions were rejected during the evolution of the species being compared [57] [58] [59] [60] . Noting the similarity between rejection of substitutions in DNA (revealed by the multi-species alignments) and protection of DNA from nucleases by protein binding (biochemical footprinting assays), Tagle et al. 61 called these 'phylogenetic footprints' and predicted that they would be reliable indicators of transcription factor bindingeven for transcription factors that have not yet been discovered. This prediction was validated in multiple studies of individual genes and gene families [62] [63] [64] (FIG. 1b;   TABLE 1 ). Subsequently, this approach was part of elegant work to identify regulatory motifs in promoters and 3ʹ untranslated regions of mammalian genomes 65 and also in entire genomes from multiple Drosophila species 66, 67 . Because this approach is not dependent on a library of known TFBS motifs, novel motifs are discovered, and these can predict expression patterns of the regulated genes 65 (TABLE 1) .
Box 2 | Bioinformatics approaches
Bioinformatics approaches for cis-regulatory module identification typically use supervised machine learning, in which models are built from trusted training data and then used for prediction. Training data are generally derived from experimental data, such as binding footprints or regions identified by chromatin immunoprecipitation followed by high-throughput sequencing (ChIP-seq) that are enriched for a specific transcription factor, or they are the result of functional assays for enhancer or other cis-regulatory module (CRM) functions.
Finding matches to known motifs
Transcription factor binding site (TFBS) motifs are most often described using a position weight matrix (PWM): a model for a fixed length sequence that specifies the probability of each nucleotide at each position. Given a background model, a PWM can be converted to a position-specific scoring matrix (PSSM), which can directly compute the log odds score of a given string being generated by the PWM model versus the background model. The log odds score evaluates a single site but does not assess the likelihood of finding such a site in a longer sequence. Several approaches can be used to evaluate the statistical significance of these log odds scores, either through simulating the score distribution 134, 135 or interrogating a sequence database 136 .
Finding clusters of motif matches
Many approaches have been developed for identifying motif clusters. Simply scanning genomic sequence for windows containing multiple motif matches has been used for predicting CRMs 47 , but choosing appropriate significance thresholds can be difficult. One of the first machine-learning approaches for CRMs used the positions and scores of strong matches to PWMs as predictors in a logistic regression model. An advantage of such an approach is the ability to capture not just clustering of motifs but also constraints on the organization of motifs in a cluster (such as order). Regardless of the approach used to find clusters, several methods have been developed that use statistical models to assess the significance of motif clusters in a sequence 46 , even in the presence of constraints on organization 136 . Nature Reviews | Genetics Evidence of evolutionary constraint over longer segments of non-coding DNA (hundreds of base pairs) can reveal entire CRMs. Early examples are the use of human-mouse alignments to discover enhancers of immunoglobulin 68 and interleukin genes 69 . CRMs predicted by non-coding constraint have been validated as enhancers at a very high rate using reporter gene assays after transfection of cells 70, 71 or production of transgenic Ciona intestinalis sea squirts 72 , Fugu rubripes pufferfish 73 or mice 71 (FIG. 2) . Hundreds of human noncoding DNA segments showing signatures of extreme evolutionary constraint have been tested for the ability to drive tissue-specific expression in transgenic mouse embryos, and over half were validated 34, 74 . In most studies (TABLE 1) , predictions were made in the vicinity of regulated genes [69] [70] [71] [72] , or a genome was scanned for evidence of extreme evolutionary constraint (for example, conserved from humans to fish). A much lower validation frequency is observed when these criteria are relaxed 75 (TABLE 1) . Thus, many constrained non-coding sequences may not be overtly involved in gene regulation, but constraint combined with other features can be effective for CRM prediction.
From alignments to CRM prediction when TFBSs are known. Combining inference of constraint from multispecies alignments with clusters of TFBS motifs can improve CRM prediction. Many known CRMs and in vivo-bound TFBS motifs were found to be conserved between humans and rodents 15 or among Drosophila species 66, 67, 76 , and the specificity of CRM prediction was improved when TFBS motif instances were restricted to those that are conserved in other species [77] [78] [79] . Blanchette et al. 80 searched mammalian genomes and alignments for clusters of evolutionarily constrained TFBS motif instances. These predicted regulatory modules (PReMods) encompass a large fraction of known CRMs (TABLE 1) . A subsequent genome-wide mapping of likely enhancers found that over 40% of the DNA segments occupied by the co-activator p300 (which ; in the lower panel, nucleotides that differ from the reference sequence (mouse) are coloured blue, and phylogenetic footprints are indicated by boxes labelled by transcription factors that are known or predicted to bind to them. c | Chromatin immunoprecipitation followed by high-throughput sequencing (ChIP-seq) assays should show peaks in CRMs. A subset of transcription-factor-bound DNA segments will not have a motif instance, which can result from interactions with another bound site. GATA1, GATA-binding factor 1; KLF, Krüppel-like factor; TAL1, T cell acute lymphocytic leukaemia protein 1; TF, transcription factor. . When DNA segments with more than one conserved instance of a given motif are tested, they validate at a high rate in transgenic fish and mice (TABLE 1) .
Other efforts focus on specific cell types: for example, using TFBS motifs for known haematopoietic transcription factors in addition to multi-species alignments 83 . A limited set of these predictions was tested, and all were validated (TABLE 1) . Recently, Narlikar et al. 84 predicted heart enhancers by applying a model of known and novel TFBS motifs learned from a large set of known heart enhancers to conserved non-coding sequences. This model predicts 42,000 heart enhancers in humans. Of these, 26 were tested in transgenic fish, and an impressive 62% of these were validated.
Although a CRM may be constrained among species, individual TFBS motif instances can tolerate sequence-level change 56 . Modelling the evolution of CRMs can capture the signatures of this change without assuming sequence-level conservation. The MorphMS model 85 identifies regions in an existing pairwise alignment that fit an evolutionary model derived from a set of existing TFBS motifs and was found to have the best performance for recovering known D. melanogaster CRMs in a comparison of *Most assays monitor the ability of the predicted cis-regulatory modules CRMs (preCRMs) to drive expression of a reporter gene, either in a consistent, tissue-specific manner in the indicated animal ('transgenic') or at a significantly elevated level in appropriate cell lines ('transfected cells'). Other assays are the discovery of preCRMs in proximity to genes with a predicted regulatory pattern ('regulated gene proximity') and occupancy in vivo by a transcription factor ('transcription factor occupancy'). A version of this table with additional fields is available in Supplementary information S1 (table) . Ahab, algorithm for predicting CRMs using a thermodynamic model for transcription factor binding; AVID, BLASTZ, CHAOS, GUMBY, megaBLAST, MLAGAN, mVISTA, PipMaker, VISTA and yama, pairwise and multiple sequence aligners; CIS-ANALYST, FLY ENHANCER and SCORE, programs for finding clusters of matches to motif patterns; cisModule, an algorithm for inferring CRM locations and transcription factor binding site (TFBS) motifs within them; COMET, clusters of motifs E value tool; CREAD, a package of programs for motif analysis and CRM prediction and evaluation; E2F4, E2 promoter binding factor 4; enhancer_classifier, identifies heart enhancers based on sequence features such as known and putative transcription factor binding specificities; ESPERR, evolutionary and sequence pattern extraction through reduced representations (uses training examples to learn encodings of multispecies alignments into reduced forms tailored to predict CRMs of other functional classes); GATA1, GATA-binding factor 1; H3K4me1, monomethylation of lysine 4 of histone H3; HMM, Hidden Markov model; HS, hypersensitive site; LCR, locus control region; LRA, logistic regression analysis; MYOD, myoblast determination factor; NRF1, nuclear respiratory factor 1; PATSER and ScanACE, programs that search for matches to TFBS motifs; POU3F2, POU domain class 3 transcription factor 2; PPV, positive predictive value; PreMOD and TFBScluster, pipelines for predicting CRMs based on conservation of clusters of TFBS motifs; RET, rearranged during transfection proto-oncogene; SIM2, single-minded homologue 2 gene.
several computational approaches 17 . A promising extension of this approach incorporates gain and loss of binding sites 86 , but owing to additional computational complexity this approach has not yet been used for genome-wide CRM detection.
From alignments to CRM prediction when TFBSs are unknown.
Because not all TFBS motifs are known, it is desirable to develop 'motif-blind approaches' to prediction that are not limited by current knowledge of TFBS motifs. Approaches that search for patterns in a training set of known CRMs that distinguish them from non-functional DNA have been used for this purpose. One method finds patterns in multi-species alignment columns with significantly more frequent occurrences in training sets of alignments of known CRMs compared with alignments of presumably nonfunctional DNA 87 . The resulting 'regulatory potential' score has been computed across the human and mouse genomes that are aligned with the genomes of multiple mammals. Like the approaches based on modelling CRM evolution, this can capture signatures of change rather than just constraint; however, it uses heuristics rather than an explicit evolutionary model. In the vicinity of erythroid-regulated genes, over half of the DNA segments with a high regulatory potential that also have a preserved match to an erythroid TFBS motif are validated as enhancers in transfected cells 88 (TABLE 1; an example is the Zfpm1 R13 enhancer in  FIG. 2) . Almost all of the PReMods 80 are found in the set of DNA segments with a high regulatory potential 89 . A different approach uses multiple methods to search for words (that is, short DNA sequences) that are overrepresented in a training set of known CRMs and then further restricts the word matches to evolutionarily constrained regions 90 . The predicted CRMs that were tested were all validated both in transgenic D. melanogaster and in mice (TABLE 1) .
Advantages, disadvantages and future prospects.
The studies reviewed here demonstrate the power of comparative genomics approaches for predicting CRMs but also highlight substantial differences in the validation rate between approaches. The highest validation rates are found when focusing on genes that are likely to be regulated by a designated set of transcription factors: for example, when searching for conserved instances of TFBS motifs for haematopoietic regulators around genes that are expressed in particular blood lineages. Furthermore, studies that test fewer CRMs tend to have higher validation rates. Perhaps it is not surprising that more comprehensive tests that include genes that are subject to a wider variety of regulatory mechanisms, such as the project examining constrained non-coding sequences on human chromosome 21 (REF. 75 ), reveal limited activity of the tested predictions. But the bulk of these studies show partial success of these approaches under favourable circumstances -that is, involving known transcription factors and TFBS motifs -and a set of genes responding to a particular stimulus or differentiation pathway.
Some caveats should be kept in mind when evaluating the conservation-based methods. Only a small subset of CRMs is likely to be discovered by extreme evolutionary constraint: for example, if they are conserved from humans to chickens or fish. Although extreme conservation is a strong predictor of developmental enhancers, the approach does not work equally well in all tissues 74 . Also, perhaps less than 5% of mammalian CRMs show conservation outside eutherian mammals 91 . A major limitation of most comparative approaches is that they are not designed to find CRMs that are active in only one species or that are changing in a lineage-specific manner, such as the enhancer GATA1 hit-positive 68 (GHP68) (FIG. 2) . It would be expected that CRMs that are adaptive for a species show evidence of rapid evolutionary change, but these will be missed by comparative approaches driven by a search for purifying selection. Indeed, some studies now indicate that most CRMs are species-specific 92 . In future studies, comparative approaches can be developed that cover both closely related and more divergent species, with the goal of finding lineage-specific and preserved functional sequences, respectively 93 .
Additional types of regulatory regions should be tested. A study of silencer and insulator activities for 47 DNA segments from a 1 Mb region containing cystic fibrosis transmembrane regulator (CFTR), and flanking genes Three examples show that whereas some enhancers are subject to strong evolutionary constraint over long phylogenetic distances, others show less constraint and still others appear to be lost in a lineage-specific manner. a | The deeply preserved enhancer R13 (REF. 88) in the gene zinc finger protein multitype 1 (ZFPM1) has the following features: it is bound in vivo by GATA transcription factors ('TFs' in the figure) and TAL1 in both human and mouse erythroid cells, as shown by chromatin immunoprecipitation followed by high-throughput sequencing (ChIP-seq) data 20, 139, 140 ; it has a strong signature of evolutionary constraint by the phyloP score 141 ; and it contains phylogenetic footprints for a GATA-binding factor 1 (GATA1) binding site motif (highlighted in orange). The genome browser views are shown at an increasing resolution, as is appropriate for each feature; known enhancers are shown as purple rectangles. b | The enhancer GATA1 hit-positive 10 (GHP10) 112 is occupied by erythroid transcription factors in mice and humans, but other predicted cis-regulatory modules (CRMs) for the chondroitin sulphate synthase 1 (CHSY1) gene differ between mice and humans. GHP10 has a sparser phyloP signal for constraint compared to the R13 enhancer in Zfpm1 but preservation of some GATA1 binding site motifs. c | The enhancer GHP68 (REF. 112 ) is found in an intron of the mouse abhydrolase domain containing 2 (Abhd2) gene, but no GATA1 occupancy is observed at this position in humans. By contrast, human-specific binding is seen upstream from ABHD2 (as shown by the asterisk). Although a GATA1 binding site motif is conserved in the rodent, horse and cow homologues of GHP68, no homologous sequence is found in humans or rhesus monkeys, indicating a primate-specific deletion that leads to a negative signal for phyloP. Grey lines in the alignments indicate that no orthologous sequence is found in the comparison species. Chromatin immunoprecipitation (ChIP). A method for purifying the DNA segments that are in close contact with a transcription factor in living cells. After crosslinking DNA to native proteins in cells and preparing sheared chromatin, antibodies that specifically react with one transcription factor are used to isolate the DNA bound to that transcription factor.
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ChIP followed by high-throughput sequencing (ChIP-seq). A technique for mapping the particular segments of DNA purified by chromatin immunoprecipitation (ChIP): it involves massively parallel short-read (second generation) sequencing and then aligning the reads to a reference genome. ChIP-seq is often highly accurate and has close to whole-genome coverage.
Hidden Markov model
A statistical model in which internal states are not visible but the outputs of these states are, and the outputs can therefore be used to infer the internal states. This model can be used to determine biologically relevant states from chromatin immunoprecipitation followed by high-throughput sequencing (ChIP-seq) data sets.
revealed that signatures of constraint did not improve predictions of these types of regulatory regions 94 . Largerscale studies and the development of models incorporating more types of features could be productive. Also, developing quantitative models that predict expression levels and patterns of target genes, followed by largescale experimental testing, will be essential to evaluating progress towards a more complete understanding of the genomics of gene regulation.
High-throughput assays of epigenetic marks
Mapping epigenetic features associated with CRMs. Given the limitations of methods based on sequence motifs and comparative genomics, direct measurement of diagnostic epigenetic features should lead to improved methods for CRM prediction 95 . Particular epigenetic features are highly correlated with CRMs, and progress is being made in finding combinations of these features that may distinguish different types of CRM.
Chromatin immunoprecipitation (ChIP) is a reliable method for purifying DNA that is in close contact with a particular protein in animal cells, as long as the interactions are sufficiently stable and a highly specific antibody is available 96, 97 . With the introduction of sequence census methods 98 , in which the immunoprecipitated DNA is analysed on massively parallel short-read sequencers, the DNA that is in close contact with the protein of interest can be determined with remarkable sensitivity and useful resolution (200-300 bp) across an animal genome. This methodology, which is called ChIP followed by high-throughput sequencing (ChIP-seq), is being applied in many cell types to find DNA that is bound by a wide range of transcription factors or that is associated with chromatin having particular histone modifications (FIGS 1c,2) . DNase hypersensitivity, which is a general biochemical feature of CRMs, can also be mapped by sequence census methods called DNase-seq 99, 100 . Consortia of multiple laboratories, such as ENCODE 101 , modENCODE 102, 103 and the US National Institutes of Health (NIH) Roadmap Epigenomics Mapping Consortium 104 , are working in a coordinated manner to expand the coverage of cell types, transcription factors and modifications and other epigenetic features. This section will summarize advances in using direct epigenetic information to predict two classes of CRM: promoters and enhancers.
Predicting promoters based on TSSs. The TSS is almost invariably located within the promoter
, and promoters can be successfully predicted from the locations of TSSs 105, 106 . One study tested 152 predicted promoters by reporter gene assays in a range of mammalian cell types and found that 91% were active in at least one cell type (TABLE 1; BOX 3) . This remarkably high validation rate, which was confirmed in later studies 106 , shows that knowledge of a TSS leads to reliable promoter prediction, with no overt bias for sequence composition or motifs. A different epigenetic feature -namely, the histone modification trimethylation of histone H3 at lysine 4 (H3K4me3) -is also effective for predicting active promoters 81 (TABLE 1) .
Predicting enhancers based on epigenetic features of CRMs. Enhancers have now been predicted with a high accuracy based on several epigenetic features, including histone acetylation 107 , the histone modification H3K4me1 (REF. 108 ) and binding of the co-activator p300 to a DNA segment 109, 110 (TABLE 1) . The reporter gene assays were conducted in either transfected cultured cells or in transgenic mouse embryos
. Even when the tests were conducted on large groups of predicted enhancers, tissue-specific expression was driven by 75-87% of the DNA fragments, showing that these epigenetic marks are robust, accurate predictors of enhancers. Furthermore, a multivariate hidden Markov model that combined information on several histone modifications provided excellent predictive power for tissue-specific enhancers in humans 111 (TABLE 1) .
The success rate of predicting enhancers based on their occupancy by tissue-specific transcription factors is encouraging, but it is not as high as using the epigenetic marks just described (TABLE 1) . For instance, of a set of 63 mouse DNA sequences bound in vivo by GATA1, only half are active as enhancers in transfected cells in culture 112 . As expected from the association of CRMs with evolutionary constraint discussed previously, the set of validated enhancers includes some DNA segments with deep phylogenetic conservation of DNA and conservation of binding between species, but it also includes DNA segments bound in mice but not in humans (FIG. 2) . A similar fraction of DNA segments (40%) occupied by myoblast determination protein (MYOD) was validated as having enhancer activity after testing in transfected cells 19 (however, applying a similar threshold for validation to that used in the GATA1 study shows that, rather than 40%, about 50% had enhancer activity) (TABLE 1) .
Examination of occupancy by multiple transcription factors increases the predictive power of the data. Wilson et al. 113 identified DNA segments jointly occupied by five haematopoietic transcription factors in megakaryocytes. Rather than testing these directly for enhancer function, they looked for genes that were previously not known to be important for haematopoiesis that are in the vicinity of the jointly occupied DNA segments. The function of these genes was then tested using a knockdown strategy; all but one of the knockdowns caused a reduction in blood cell production 113 (TABLE 1) . Thus, the jointly occupied DNA segments were excellent predictors of likely enhancers -a finding that immediately led to novel insights into haematopoietic regulation.
Advantages, disadvantages and future prospects. Direct experimental determination of biochemical features that are associated with promoters and enhancers has many advantages over computational methods. The strategy is grounded in decades of work on the biochemical mechanisms of transcriptional regulation, and the proteins and histone modifications being assayed are strongly associated with regulation. The experimental approach is now almost exclusively based on high-throughput sequencing and mapping to reference genomes, and whereas these methods do have some biases, they allow almost Nature Reviews | Genetics 
Morpholino oligonucleotides
Synthetic oligonucleotides in which the ribose portion of the nucleotide is replaced a morpholino compound; these are more stable than RNA and can be used to interfere with gene activity in transgenic zebrafish.
complete coverage of animal genomes. These recent advances are exciting, but more research is needed to assess the sensitivity and specificity of both the comparative and the epigenetic methods. For example, a method based on p300 occupancy predicts hundreds of heart enhancers, whereas almost none of the enhancers predicted by very stringent constraint on non-coding sequences is active in the heart 110 (TABLE 1) . However, another approach applying a motif-based classifier to less-stringently constrained sequences predicts 42,000 heart enhancers 84 . Both the latter and the p300-based predictions are validated at impressive rates (TABLE 1) ,
Box 3 | Methods for validation of predicted CRMs
The most common methods for demonstrating that a DNA segment can function in the regulation of gene expression are gain-of-function assays after transferring a reporter gene that encodes a readily assayed enzyme into cultured cells (transfections; panel a of the figure) or whole animals (transgenic assays: panel b of the figure). For promoter assays (upper part of panel a), the predicted cis-regulatory module (CRM) is placed in front of a reporter gene (namely, luciferase (Luc)) lacking a promoter and transferred into cultured cells. For enhancer assays (lower part of panel a; panel b), the predicted CRM is added to a reporter gene that is already driven by a low-activity promoter (pr). The enzyme assays after cell transfection give a quantitative estimate of enhancer activity (right-hand side of panel a; the box plots show the distribution of enhancement measurements for multiple determinations 88, 112 ). Information about tissue-and developmentalstage specificity is limited by the cell types investigated by transfection. Staining transgenic mouse or fly embryos carrying the lacZ gene encoding β-galactosidase shows blue staining in the tissues in which an enhancer is active, providing information on tissue specificity. Loss-of-function tests of predicted CRMs (preCRMs) -for example, by targeted deletion -are desirable, but they are more difficult and not used as frequently.
Other methods for investigating predicted CRMs examine the expression patterns of presumptive target genes. The most common assumption is that the gene with a transcription start site that is closest to the predicted CRM is the likely target. If a likely target gene has an expression pattern expected for the features used to predict CRMs, such as expression in muscle for CRMs predicted by the occurrence of binding site motifs for muscle determination factors, then this supports the validity of the enhancer. Of course, this is not as powerful as a direct experimental demonstration.
A novel approach that uses expression of presumptive target genes is to search for genes that were not previously known to be required in a tissue of interest. Instead of testing the function of the preCRMs, the effect of specific knockdown of the presumptive target can be monitored after treating with, for example, morpholino oligonucleotides that interfere with gene function. Defective development or aberrant function of the tissue would serve to validate the activity of the predicted CRMs.
Prediction of binding by a transcription factor to a DNA sequence can be tested by measurement of occupancy in vivo using, for example, chromatin immunoprecipitation (ChIP). This method is appropriate for determining that a protein is bound to the DNA sequence, but it provides no information about a role in regulation. The older literature contains many studies of binding by purified proteins or proteins in nuclear extracts to specific DNA sequences. Studies with appropriate controls to distinguish specific binding have some use, but these results are largely superseded by current ChIP followed by high-throughput sequencing (ChIP-seq) data on in vivo occupancy.
ChIP-exo
An extension of ChIP-seq that includes exonuclease trimming after immunoprecipitation to increase the resolution of the mapped transcription-factorbound sites.
suggesting that at least some of the current ChIP-seq data sets are missing some CRMs.
One disadvantage of the direct experimental approach is that epigenetic marks must be mapped in tissues and at times of development that are informative to the question at hand. Ideally, all transcription factors and all histone modifications would be mapped in all cell types and developmental stages in the species of interest. Achieving this will be difficult for many reasons beyond budgetary ones, such as the limited number of regulatory proteins for which ChIP-quality antibodies are available and the difficulty in obtaining sufficient amounts of many cell types. Although the ideal scenario of completeness may never be achieved, a substantial amount of predictive power is likely to be attained as the regulatory landscape is mapped in a large number of cell types. DNase-hypersensitive sites are being mapped in a broad range of cell types and tissues 99, 100 . These are general marks for sequences that are potentially involved in regulation; almost all known CRMs reside in such hypersensitive sites. Some regulatory regions, especially promoters but also some enhancers 81, 105, 114 , are active in multiple cell types. Many others are bound by transcription factors in specific cell types and can only be identified when assays are done in those cells. The genome-wide maps of epigenetic marks provide a valuable resource for CRM prediction, and one that will increase in value as a broader range of cell types and developmental stages are interrogated.
A caveat in using the genome-wide maps of factor occupancy is that some of these protein-DNA interactions may not have an active role in regulation. The very deep coverage achieved in recent ChIP-seq studies reveals binding at thousands of sites, but for well-known, lineage-specific transcription factors, the number of bound sites substantially exceeds the number of genes with significant changes in expression in that lineage. For example, over half of all genes are bound by the determination factor MYOD in muscle cells 19 . Integration of information on multiple epigenetic features 111 may allow the transcription-factor-occupied segments to be partitioned into classes with more specific predicted functions (including no obvious function), thereby giving more accurate predictions.
Future work is also likely to interrogate more diverse functions. As noted before, CTCF is almost always found at mammalian insulators with enhancer-blocking activities 115 , but it is currently unclear what fraction of the large numbers of CTCF-occupied segments have this activity. We expect that such surveys will be conducted in the near future.
The bulk of the results summarized in this section were derived from ChIP-seq approaches that yield assignments of transcription factor occupancy at a resolution of 200-300 bp. New technologies should refine that resolution substantially. Already, deep sequencing of DNase-sensitive regions is revealing small segments that correspond to transcription factor binding sites (10-20 bp) 100, 116 , and a new method ChIP-exo incorporates exonuclease trimming into ChIP-seq to give very high-resolution data 117 . Identifying the gene (or genes) that is responsive to the transcription factors at enhancers has been problematic, and many studies used the closest active gene as a proxy for the target gene. However, the high-throughput versions [118] [119] [120] of chromosome conformation capture technologies yield three-dimensional interaction maps that are providing exciting new insights into how distal CRMs interact with target promoters.
Recommendations
Comprehensive identification of CRMs is not currently possible from sequence comparisons alone, whether used to find clusters of TFBS motifs or to find evidence of strong constraint in DNA. Clusters of TFBSs do not provide sufficient specificity to be used in large-scale investigations, whereas restricting a search to strong constraint will miss a large number of, even most, transcription-factor-occupied segments. By contrast, highquality, high-throughput biochemical data on epigenetic features will capture a large fraction of CRMs, and of course the fraction captured will increase as the amount of data increases, particularly as more diverse cell types and conditions are assayed. This information is becoming more readily available to individual investigators, either through their own efforts or by using the publicly released data from large consortia. We recommend that this be the starting point in searches for potential regulatory regions, but that both evolutionary information and motif patterns should then be used to bring in insights about potential functions and to organize experimental tests
We expect that future work will show that patterns in the TFBS motifs and their conservation (or lack thereof) can lead to strong and precise functional predictions. At the present time, investigators can use de novo motif discovery 121 to predict binding partners of transcription factors and to guide further ChIP experiments. It may be productive to partition the transcription-factoroccupied segments into motif classes and to assess whether these tend to associate with induction, repression or other activities of likely target genes. Significant associations will probably lead to mechanistic insights.
Perspectives
Although most of the evolutionary analysis in this Review focuses on purifying selection that has taken place across a wide evolutionary timescale, recent changes in DNA sequences can also affect gene regulation. Some in vivo TFBSs are allele-specific 122 : for example, when the transcription factor binds to the maternal but not the paternal allele in heterozygotes. Genetic variation affecting the affinity of regulatory proteins for CRMs is likely to explain some of the differences in gene expression between individuals 123, 124 . Allele-specific binding by transcription factors or chromatin opening has been found at loci associated with susceptibility to cancer 4, 5 and to diabetes 125 . These studies show the impact of recent evolution in CRMs and point to the medical importance of understanding these recent changes.
Future work should focus on integrating the many types of epigenetic information, building on recent efforts 103, 111, 126, 127 . These could be extended to include multi-species comparisons, not only of the underlying DNA sequences (for example, to infer evolutionary constraint) but also of information about occupancy.
Similarly, information about in vitro binding affinities 128 and motif patterns needs to be brought into the analysis. Such integrations will be challenging, and using them to formulate testable hypotheses will be even more challenging. However, these seem to be reachable goals, and it will be exciting to work towards them. Indeed, the resulting hypotheses will constitute an initial formulation of a possible regulatory code. The hypotheses will need to be tested experimentally, probably starting with conventional gain-of-function reporter gene assays. Larger-scale efforts are needed, which require development of higher throughput assays. Furthermore, synthetic biology approaches 54 will provide powerful tests of the hypotheses and will hopefully lead to a better understanding of the regulatory code.
Box 4 | Steps in prediction and analysis of CRMs
Mapping epigenetic features as the preferred first step Investigators using genomic data to find transcriptional regulatory regions in animal DNA will find all three approaches to be useful, but each should be used for a different aspect of their investigations. If data on epigenetic features can be obtained, that should be the starting point for predicting cis-regulatory modules (CRMs). High-quality data sets on such features provide a reasonably unbiased view of the regulatory landscape. We expect that most of the important regulatory regions will be present, assuming the relevant transcription factors are examined in an appropriate cell type for the question of interest. Even if that is not the case, the profile of DNase-hypersensitive sites in a battery of cells across loci of interest could be a good initial guide 101 .
Comparative approach can partition candidates
The approaches based on multi-species alignments can then be applied to infer the evolutionary histories of the predicted CRMs and the motifs within them. Indeed, a large number of CRMs may be predicted on the basis of epigenetic features, and partitioning them on the basis of the extent of phylogenetic conservation can be informative. Conservation can prioritize candidates for functional testing; conservation of transcription factor binding site (TFBS) motifs across multiple species of Drosophila was found to be strongly associated with regulatory function 66 , and GATA-binding factor 1 (GATA1)-occupied DNA segments with TFBS motifs that are deeply preserved across mammals were active as enhancers substantially more frequently than those with lineage-specific motifs 112 . However, the hypothesis that evolutionary constraint helps to distinguish transcription-factor-occupied segments that are active from bound but passive sites needs much more extensive testing. Most DNA segments that are bound by a liver transcription factor in one mammal are not bound by that factor at the homologous DNA in a different mammal 92, 137 , and some lineage-specific occupied segments are active in regulation (FIG. 2) . Thus we recommend using conservation as a means to partition predicted CRMs and to infer their history, but not as a filter to remove them from further consideration.
Partitioning predicted CRMs by depth of conservation may provide insight into the functions of their target genes. An initial exploration of that question found significant enrichments that differed for CRMs conserved to distinct phylogenetic distances 91 , and this could be a productive area for more complete investigation. Also, the depth of conservation could reflect variation in the severity of constraint on different aspects of regulatory mechanisms. For example, an interesting hypothesis to test is that CRMs conserved across all vertebrates have a more central mechanistic role in regulation, whereas lineage-specific CRMs could have a more peripheral role by modulating that core activity.
Analysis of TFBS motifs for functional prediction
Just as analysis of conservation leads to insights into CRMs predicted by epigenetic features, so will an analysis of TFBS motifs. It is still important to find TFBS motifs for several reasons, including generalizing insights from a well-studied set of CRMs to whole-genome analysis, for making predictions about function and for understanding the structure of a particular CRM. Epigenetic marks have limited resolution, and motif-based bioinformatics approaches can provide a more detailed analysis of the properties of a module. Indeed, the conservation analysis just discussed is most informative when it is applied to the TFBS motifs rather than the entire transcription-factor-occupied segment 67, 91, 112, 132 . Furthermore, recent work shows that combining one or more data sets on epigenetic features with TFBS motif models improves the ability to find transcription-factor-occupied sites 138 .
